Recovery of Lung Function After 149 Days on Extracorporeal Membrane Oxygenation for COVID-19

Author:

Suero Orlando R.12,Valluri Sri Kartik13,Farias-Kovac Mario H.12,Simpson Leo45,Loor Gabriel67,Guerra Diana M.12,Diaz-Gomez Jose L.12,Chatterjee Subhasis789

Affiliation:

1. 1Division of Cardiovascular Anesthesia, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas

2. 3Department of Cardiovascular Anesthesiology, The Texas Heart Institute, Houston, Texas

3. 2Division of Critical Care Medicine, Department of Anesthesiology, Baylor College of Medicine, Houston, Texas

4. 4Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas

5. 5Department of Cardiology, The Texas Heart Institute, Houston, Texas

6. 6Division of Cardiothoracic Transplantation and Circulatory Support, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas

7. 7Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas

8. 8Division of Trauma and Acute Care Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas

9. 9Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas

Abstract

Abstract This report highlights survival and the patient’s perspective after prolonged venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19–related respiratory failure. A 36-year-old man with COVID-19 presented with fever, anosmia, and hypoxia. After respiratory deterioration necessitating intubation and lung-protective ventilation, he was referred for ECMO. After 3 days of conventional venovenous ECMO, he required multiple creative cannulation configurations. Adequate sedation and recurrent bradycardia were persistent challenges. After 149 consecutive days of ECMO, he recovered native lung function and was weaned from mechanical ventilation. This represents the longest-duration ECMO support in a survivor of COVID-19 yet reported. Necessary strategies included unconventional cannulation and flexible anticoagulation.

Publisher

Texas Heart Institute Journal

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3